Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis 28/06/2022 15:11 Peyrin‑Biroulet et.al.; BMC Gastroenterology 2022 Jun 8;22(1):291 קרא עוד ←
